Related Experiment Video
Updated: Jun 7, 2025

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
A Huge Conjunctival Atypical Fibroxanthoma.
Estefania Ramirez Marquez1, José J López-Fontanet1, Gerardo Torres2
1Ophthalmology, University of Puerto Rico School of Medicine, Medical Sciences Campus, San Juan, PRI.
A large conjunctival atypical fibroxanthoma (AFX) in a Hispanic male invaded the eye and surrounding muscles. Treatment required exenteration, with ongoing monitoring planned for this rare tumor.
Area of Science:
- Ophthalmology
- Oncology
- Dermatopathology
Background:
- Conjunctival atypical fibroxanthoma (AFX) is a rare mesenchymal tumor.
- AFX typically presents as a benign lesion, but malignant transformation can occur.
Observation:
- A 50-year-old Hispanic male presented with a rapidly growing conjunctival lesion.
- Biopsy confirmed atypical fibroxanthoma with a component of squamous cell carcinoma.
- The tumor exhibited significant intraocular and extraocular muscle extensions.
Findings:
- The conjunctival atypical fibroxanthoma (AFX) demonstrated aggressive growth and invasion.
- Surgical exenteration was necessary due to the tumor's extensive spread.
- The case highlights the potential for aggressive behavior in conjunctival AFX.
Implications:
- This case underscores the importance of vigilant monitoring for conjunctival lesions.
- Aggressive surgical management may be required for advanced AFX.
- Further research into the behavior and treatment of conjunctival AFX is warranted.
More Related Videos
06:46Ortho- and Ectopic Zebrafish Xeno-Engraftment of Ocular Melanoma to Recapitulate Primary Tumor and Experimental Metastasis Development
Published on: September 4, 2021
10:14Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
Related Concept Videos
Introduction to Fibroblasts
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...